Evolutions in the Management of DMD: Treatment Implications for the Present and Future


Activity Info

New genetic and non-genetic therapies for Duchenne muscular dystrophy are in clinical trials and being approved. Deciding which therapy is right for which patient is evolving. This education addresses dystrophin disruption and restoration, the latest clinical trial results across various treatment modalities, and a case to consider new patient management approaches.


Webinar | CME (AMA PRA Category 1 Credit) | 0.50 - 30 mins | Internal Medicine | Neurology | Neuromuscular Specialist | Pediatrics | Family Medicine | Nurse | Nurse Practitioner | Physical Medicine & Rehabilitation | Online | Pharmacist | Physician Assistant | Duchenne Muscular Dystrophy (DMD) | ANCC | 

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA